More bad news came in 2025. UnitedHealth Group reported lower-than-expected first-quarter earnings in April. The company ...

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth Group shares appear undervalued after 50% decline, and concerns about a potential DOJ investigation seem ...

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...

The nation’s two largest Medicare Advantage (MA) insurers say they support reforming the federal program to rein in certain ...

But, less than two months later, the company is in a state of free fall. Its collapse reflects not simply the troubles of the ...

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based ...

UnitedHealth raised its dividend and replaced its CEO amid scrutiny over Medicare billing and a nearly 40% stock decline this ...

UnitedHealth Group is being investigated for possible Medicare fraud, according to The Wall Street Journal, sending shares of ...

The U.S. Department of Justice is carrying out a criminal investigation into UnitedHealth Group for possible Medicare fraud, ...

The company’s stock has declined over its financial performance and the sudden replacement of its CEO.